Kasradze Tamar, Didbaridze Tamar, Tchokhonelidze Irma
Tbilisi State Medical University, Tbilisi, Georgia.
Nephrology Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, 9 Tsinandali Street, 0144, Tbilisi, Georgia.
J Nephrol. 2025 Jul 1. doi: 10.1007/s40620-025-02315-4.
The primary challenge for hemodialysis (HD) patients using permanent tunneled cuffed catheters is to prevent catheter-related bloodstream infections. This study assessed the effectiveness of sodium bicarbonate in preventing catheter-related bloodstream infections and compared its efficacy to antibiotic-containing locks.
DESIGN, MATERIALS, AND METHODS: We conducted a prospective single-center, open-label, cohort study over 30 months with the aim to compare three cohorts: cohort I employed 8.4% sodium bicarbonate solution lock, cohort II employed 0.5 mg/ml gentamicin/acid citrate dextrose solution lock, and cohort III employed unfractionated conventional heparin 5000 U/ml solution lock. The primary endpoint was the first episode of catheter-related bloodstream infection, while the secondary endpoint was catheter loss due to catheter-related bloodstream infection.
This study involved 204 HD patients with permanent tunneled cuffed central venous catheters (CVCs). A total of 58 cases of catheter-related bloodstream infection were documented. In the sodium bicarbonate-lock cohort, infection occurred in 17.24%, in the gentamicin/acid citrate-lock cohort in 36.21%, and in the heparin-lock cohort in 46.55%. Patients with sodium bicarbonate and gentamicin/acid citrate locks exhibited a statistically significant lower risk of developing infections (0.4/1000 catheter days and 0.7/1000 catheter days, respectively) compared to patients with heparin-lock (1.4/1000 catheter days). Patients with heparin lock faced a higher risk of losing a catheter due to infection compared to those with gentamicin/acid citrate lock and sodium bicarbonate-lock (Hazard Ratio (HR) = 1.26, 95% Confidence Interval (CI) [1.09-1.46], P = 0.001) and (HR = 1.10, 95% CI [1.01-1.19], P = 0.024).
The sodium bicarbonate locking solution demonstrated an infection-free catheter survival comparable to that of the gentamicin citrate solution and significantly decreased catheter-related bloodstream infection compared to heparin locks.
使用永久性带隧道涤纶套中心静脉导管的血液透析(HD)患者面临的主要挑战是预防导管相关血流感染。本研究评估了碳酸氢钠在预防导管相关血流感染方面的有效性,并将其疗效与含抗生素封管液进行比较。
设计、材料与方法:我们进行了一项为期30个月的前瞻性单中心、开放标签队列研究,旨在比较三个队列:队列I采用8.4%碳酸氢钠溶液封管,队列II采用0.5mg/ml庆大霉素/酸性枸橼酸盐葡萄糖溶液封管,队列III采用5000U/ml普通肝素溶液封管。主要终点是导管相关血流感染的首次发作,次要终点是因导管相关血流感染导致的导管丢失。
本研究纳入了204例使用永久性带隧道涤纶套中心静脉导管(CVC)的HD患者。共记录到58例导管相关血流感染病例。在碳酸氢钠封管队列中,感染发生率为17.24%,在庆大霉素/酸性枸橼酸盐封管队列中为36.21%,在肝素封管队列中为46.55%。与肝素封管患者(1.4/1000导管日)相比,使用碳酸氢钠和庆大霉素/酸性枸橼酸盐封管的患者发生感染的风险在统计学上显著更低(分别为0.4/1000导管日和0.7/1000导管日)。与庆大霉素/酸性枸橼酸盐封管和碳酸氢钠封管的患者相比,肝素封管的患者因感染导致导管丢失的风险更高(风险比(HR)=1.26,95%置信区间(CI)[1.09 - 1.46],P = 0.001)以及(HR = 1.10,95% CI [1.01 - 1.19],P = 0.024)。
碳酸氢钠封管溶液显示出与庆大霉素枸橼酸盐溶液相当的无感染导管存活时间,并且与肝素封管相比,显著降低了导管相关血流感染的发生率。